Mudit K. Jain, PhD
Founder and General Partner

Mudit brings two decades of entrepreneurial experiences in medical device industry across R&D, business development, company formation, and venture capital, and a global perspective to healthcare based on his experiences in USA, Ireland, and India. Mudit has a unique blend of experiences as a private venture capitalist at Synergy Life Science Partners, and as a strategic investor with Johnson and Johnson Development Corporation (JJDC). Mudit serves on multiple private company boards and one public company board.

Mudit is a co-founder and CEO of NuXcel, an electrically active medical device focused accelerator with presence in Silicon Valley, Ireland, and Minneapolis), and a co-founder of ShiraTronics, Inc. Most recently, as a General Partner with Synergy Life Science Partners, Mudit delivered top quartile performance.

Earlier in his career, Mudit held operational roles at Guidant Corporation’s Cardiac Rhythm Management Division and in petrochemical industry in India. Mudit played an important role in product development for start-ups like Epicor, Inc. (acquired: St. Jude Medical), and Cardiac Pathways Corporation (acquired: Boston Scientific). Mudit holds eight issued patents and has published numerous articles in peer reviewed publications.

Mudit currently serves on the Board of Visitors at Duke University’s Graduate School, John Hopkins University Coulter Program Oversight Board, and on the board of One Heart Health, an organization dedicated to advancing remote monitoring technologies to identify and treat cardiac disease in children across the globe. Mudit also served as Chair of TiE LifeSciences, Silicon Valley from 2012-2014.

Mudit graduated with a B.E. in Electrical Engineering from Regional Engineering College, Nagpur, India (ranked first in his class). He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.




Copyright 2019 Strategic Healthcare Investment Partners. All rights reserved.